MCAT Disease (Medium-Chain 3-Ketoacyl-CoA Thiolase Deficiency)
MCAT disease, also known as medium-chain 3-ketoacyl-CoA thiolase (MCKAT) deficiency, is a rare autosomal recessive fatty acid oxidation disorder where patients cannot properly break down medium-chain fatty acids for energy, making adequate carbohydrate (sugar) intake absolutely critical to prevent life-threatening metabolic crises characterized by hypoketotic hypoglycemia, coma, and sudden death.
What Is MCAT Disease?
MCAT deficiency is one of several fatty acid oxidation (FAO) disorders detectable through acylcarnitine profile analysis 1. This inherited metabolic disorder results from mutations affecting the enzyme responsible for breaking down medium-chain fatty acids during beta-oxidation in the mitochondria.
Key Clinical Features:
- Inheritance pattern: Autosomal recessive 1
- Acute presentations: Recurrent episodes of life-threatening illness including vomiting, lethargy, coma, and seizures 1
- Chronic manifestations: Failure to thrive, developmental delay, hypo- or hypertonia 1
- Metabolic crisis hallmarks: Hypoketotic hypoglycemia, liver disease, and potential sudden unexpected death 1
The disorder typically manifests during periods of metabolic stress when the body attempts to rely on fat breakdown for energy but cannot do so effectively.
Why Sugar (Carbohydrates) Matters Critically
The fundamental problem in MCAT deficiency is that patients cannot generate energy from fat breakdown, making glucose (sugar) their only reliable energy source—without adequate carbohydrate intake, they develop dangerous hypoglycemia without the protective ketone production that normally occurs during fasting.
The Metabolic Crisis Mechanism:
When healthy individuals fast or become ill:
- Glycogen stores deplete
- The body switches to breaking down fats
- Fatty acids are converted to ketones for brain/body fuel
- This prevents hypoglycemia
In MCAT deficiency patients:
- Glycogen stores deplete normally
- Fat breakdown fails due to enzyme deficiency
- No ketones are produced (hypoketotic state)
- Severe hypoglycemia develops rapidly
- Toxic partially-metabolized fatty acids accumulate
- This leads to encephalopathy, coma, or death 2, 3
Critical Management Principles:
Patients with MCAT deficiency must maintain continuous carbohydrate availability through:
- Avoiding prolonged fasting intervals - the maximum safe fasting time must be strictly observed 4
- Frequent carbohydrate-rich meals throughout the day
- Immediate high-carbohydrate intervention during illness - consuming simple sugars/carbohydrate drinks at the first sign of vomiting, infection, or reduced oral intake 2, 3
- Emergency intravenous glucose if oral intake is impossible - this reverses catabolism and sustains anabolism 2
Common Pitfalls and Critical Warnings:
The most dangerous scenario occurs during intercurrent illness - infections, vomiting, diarrhea, or any condition reducing oral intake can trigger rapid metabolic decompensation 3, 5. Parents and patients must have a current written emergency management plan with specialist contact numbers readily available 3.
Do not assume mild symptoms are benign - patients can appear relatively well initially but deteriorate rapidly to severe hypoglycemia, liver failure, encephalopathy, or fatal cardiac arrhythmias within hours 6, 5.
Newborn screening may not prevent all presentations - some patients present with severe ketoacidosis or metabolic crisis before screening results return 6, emphasizing the need for clinical vigilance in any child with unexplained hypoglycemia, lethargy, or liver dysfunction.
Diagnostic Approach:
When MCAT deficiency is suspected, obtain:
- Acylcarnitine profile (plasma or dried blood spot) - the primary diagnostic test 1
- Plasma amino acids and urine organic acids - comprehensive metabolic evaluation 1
- Free and total plasma carnitine levels 1
- Genetic testing for confirmatory ACAT1 gene mutations 7
Critical: Always perform a complete hypoglycemic screen when blood glucose is below 2.6 mmol/L in any previously well child 8 - this is how many cases are identified in regions without newborn screening.
The diagnosis is almost exclusively laboratory-based, as clinical presentation alone cannot distinguish MCAT deficiency from other metabolic disorders 1.